Our Team
Physicians and Clinicians
Our team brings together fellowship-trained genitourinary oncology, radiation oncology, cardio-oncology, and dedicated patient coordination.
Katy Beckermann, MD, PhD
Medical Director of Genitourinary Research
Overview: Dr. Katy Beckermann is a medical oncologist who treats kidney, bladder, prostate, and testicular cancers. She is Medical Director of Genitourinary Research at Tennessee Oncology and founding physician lead of the GU Center of Excellence, where specialists plan each patient’s care together from diagnosis through survivorship.
She chairs the GU Disease Group at OneOncology, and her team has more than a dozen clinical trials open in kidney, bladder, and prostate cancer. She earned her MD and PhD at Vanderbilt and spent years studying why some kidney cancers stop responding to immunotherapy.
Education & Training: BS Biology (Southwestern) • MD (Vanderbilt) • PhD (Vanderbilt) • Residency Internal Medicine (Vanderbilt) • Fellowship Hematology/Oncology (Vanderbilt-Ingram)
Leadership: Founding Physician Lead, GU Center of Excellence • Chair, OneOncology GU Disease Group • Program Committee, ASCO GU Cancers Symposium • NCCN Kidney Cancer Panel (2020–2024) • National PI, Kidney Cancer Research Consortium
John G. Phillips, MD, MPH
Executive Vice President of Radiation Oncology Centers
Overview: Dr. John Phillips is a radiation oncologist at Tennessee Oncology Franklin and core radiation oncology partner for the GU Center of Excellence. His clinical focus spans the modern radiation toolbox in genitourinary cancer: external beam radiation therapy (IMRT and SBRT), proton therapy at the Tennessee Oncology Proton Center, and the radioligand therapy program for advanced prostate cancer.
Dr. Phillips participates in the GU multidisciplinary clinic and tumor board. He co-leads the expansion of the Pluvicto (Lu-177 PSMA) radioligand therapy program at Franklin, with the goal of meeting patient demand for this important treatment within the community.
Clinical Philosophy: Selecting the right radiation modality for each patient, integrated with systemic therapy and surgical care across the multidisciplinary team, and managing survivorship with the same care as initial treatment.
Focus Areas: Prostate cancer radiation (all stages) • Proton therapy • Pluvicto radioligand therapy • SBRT and oligometastatic disease • Bladder preservation
David Slosky, MD
Cardio-Oncology for GU Patients
Overview: Dr. David Slosky is a cardio-oncology consultant to the GU Center of Excellence at Tennessee Oncology. He provides specialized consultation for genitourinary cancer patients, with particular focus on cardiovascular risk management during long-term androgen deprivation therapy, second-generation androgen receptor pathway inhibitors, and immune checkpoint inhibitor regimens.
Dr. Slosky partners with the GU oncology team on survivorship and risk-stratified surveillance for patients with cardiac comorbidities or treatment-related cardiovascular concerns. His expertise ensures coordinated care that optimizes both oncologic outcomes and long-term cardiovascular health.
Clinical Approach: Cardiovascular risk assessment and monitoring in GU cancer patients • ADT cardiovascular safety • ARPI cardiotoxicity prevention • ICI myocarditis monitoring • Survivorship care planning
Program Role: GU Center of Excellence Cardio-Oncology Consultant • Multidisciplinary Clinic Participant • Survivorship Planning Team Member
Ready to Connect With Our Team?
Contact our patient care coordinator to discuss your diagnosis, request a second opinion, or schedule your multidisciplinary consultation.
